Charles Mc Wherter Cyma Bay Therapeutics, Inc. (CBAY) insider trading activity

Charles Mc Wherter is President of R&D of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2024, when has been sold 46,938 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Charles McWherter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 22 2024	SELL Sale (or disposition) back to the issuer	-	46,938 Reduced 100.0%	0 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	31,938 Added 40.49%	46,938 Common Stock
Jan 19 2024	SELL Open market or private sale	$435,599 $23.67 p/Share	18,403 Reduced 55.09%	15,000 Common Stock
Jan 19 2024	BUY Exercise of conversion of derivative security	$96,799 $5.26 p/Share	18,403 Added 50.38%	18,125 Common Stock
Dec 18 2023	SELL Open market or private sale	$243,524 $21.49 p/Share	11,332 Reduced 43.04%	15,000 Common Stock
Dec 18 2023	BUY Exercise of conversion of derivative security	$56,660 $5.0 p/Share	11,332 Added 34.51%	21,504 Common Stock
Nov 17 2023	SELL Open market or private sale	$207,331 $18.28 p/Share	11,342 Reduced 43.06%	15,000 Common Stock
Nov 17 2023	BUY Exercise of conversion of derivative security	$56,710 $5.0 p/Share	11,342 Added 30.1%	26,342 Common Stock
Oct 18 2023	SELL Open market or private sale	$305,924 $14.07 p/Share	21,743 Reduced 59.18%	15,000 Common Stock
Oct 18 2023	BUY Exercise of conversion of derivative security	$108,715 $5.0 p/Share	21,743 Added 37.18%	36,743 Common Stock
Sep 18 2023	SELL Open market or private sale	$352,720 $16.22 p/Share	21,746 Reduced 59.18%	15,000 Common Stock
Sep 18 2023	BUY Exercise of conversion of derivative security	$108,730 $5.0 p/Share	21,746 Added 37.18%	36,746 Common Stock
Aug 18 2023	SELL Open market or private sale	$249,426 $11.47 p/Share	21,746 Reduced 59.18%	15,000 Common Stock
Aug 18 2023	BUY Exercise of conversion of derivative security	$108,730 $5.0 p/Share	21,746 Added 37.18%	36,746 Common Stock
Jul 18 2023	SELL Open market or private sale	$248,591 $11.43 p/Share	21,749 Reduced 59.18%	15,000 Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	$108,745 $5.0 p/Share	21,749 Added 37.18%	36,749 Common Stock
Jun 20 2023	SELL Open market or private sale	$177,471 $8.16 p/Share	21,749 Reduced 59.18%	15,000 Common Stock
Jun 20 2023	BUY Exercise of conversion of derivative security	$108,745 $5.0 p/Share	21,749 Added 37.18%	36,749 Common Stock
May 18 2023	SELL Open market or private sale	$197,480 $9.08 p/Share	21,749 Reduced 59.18%	15,000 Common Stock
May 18 2023	BUY Exercise of conversion of derivative security	$108,745 $5.0 p/Share	21,749 Added 37.18%	36,749 Common Stock

Also insider at

ETNB

89bio, Inc. Healthcare